Skip to content

Performance, safety and clinical benefits of a pre-calibrated navigated suction device

Performance, safety and clinical benefits of a pre-calibrated navigated suction device

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035670
Enrollment
25
Registered
2024-12-10
Start date
2024-12-04
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C69-C72 D32 D33 I60 I61 I62 I67.5 Q28.2 D18.1

Interventions

Group 1: Single-arm study: The participation of the subjects and the total duration of treatment relevant for the study is limited to the respective surgery due to the underlying intracranial patholog

Sponsors

Brainlab AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with intracranial pathologies with the indication for navigated neurosurgical intervention where the use of a suction device is required (e.g., resection or open biopsy surgery) - Age = 18 years - Patients are able to provide written informed consent

Exclusion criteria

Exclusion criteria: - Cranial surgeries without the need for neuronavigation - Age < 18 years - Patients are unable to give informed consent - Pregnant or nursing women

Design outcomes

Primary

MeasureTime frame
Accuracy of pointing functionality: quantitative assessment of the target registration error (TRE).

Secondary

MeasureTime frame
• Clinical accuracy: qualitative assessment of the appropriateness of navigation accuracy for the indication; • Suctioning capability: o Qualitative assessment of the appropriateness of suctioning capability for the indication; o Quantitative assessment of suctioning capability (count the number of times the Disposable Pre-calibrated Suction needed to be changed to a conventional suction); o Qualitative assessment of the capability of the Disposable Pre-calibrated Suction to stop when intended; • Safety parameters: o Qualitative assessment of the line of sight issues; o Quantitative assessment of complication rate and adverse events (count the number of complications and adverse events); o Quantitative assessment of workflow adaptions needed; Quantitative assessment of pointing/navigation accuracy (count the number of switches to a conventional navigation pointer).

Countries

Germany

Contacts

Public ContactConstantin Roder

Universitätsklinikum Tübingen

constantin.roder@med.uni-tuebingen.de+49 7071 29 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026